Abstract
MicroRNAs are endogenous small non-coding RNAs that regulate gene expression by means of partial complementarity to microRNA binding sites at their target genes. These molecules have emerged as key regulators of almost every biological process including accurate control of neuronal gene expression. The authors discuss the current state of microRNA research, including studies of psychiatric disorders (schizophrenia, autism spectrum disorder and affective disorders). Stress has also been shown to have a critical role in the development of psychiatric disorders, at least partially, through mechanisms related to neural plasticity. Synaptic connections in the brain undergo experience-dependent functional or morphological changes through complex pathways that are not yet fully understood, but for which microRNAs might have a critical role. The focus is on the role that microRNAs play in the development of psychiatric disorders and their potential to serve as biomarkers of disease as well as targets for pharmacological treatment.
Keywords: miRNA, Psychiatric disorders, Stress, BD, SCH2, MDD, RNA.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:The Dysregulation of microRNAs and the Role of Stress in the Pathogenesis of Mental Disorders
Volume: 18 Issue: 21
Author(s): Elena Ivanova*, Radosveta Bozhilova, Radka Kaneva and Vihra Milanova
Affiliation:
- Clinic of Psychiatry, University Multiprofile Hospital for Active Treatment "Alexandrovska", Sofia,Bulgaria
Keywords: miRNA, Psychiatric disorders, Stress, BD, SCH2, MDD, RNA.
Abstract: MicroRNAs are endogenous small non-coding RNAs that regulate gene expression by means of partial complementarity to microRNA binding sites at their target genes. These molecules have emerged as key regulators of almost every biological process including accurate control of neuronal gene expression. The authors discuss the current state of microRNA research, including studies of psychiatric disorders (schizophrenia, autism spectrum disorder and affective disorders). Stress has also been shown to have a critical role in the development of psychiatric disorders, at least partially, through mechanisms related to neural plasticity. Synaptic connections in the brain undergo experience-dependent functional or morphological changes through complex pathways that are not yet fully understood, but for which microRNAs might have a critical role. The focus is on the role that microRNAs play in the development of psychiatric disorders and their potential to serve as biomarkers of disease as well as targets for pharmacological treatment.
Export Options
About this article
Cite this article as:
Ivanova Elena *, Bozhilova Radosveta , Kaneva Radka and Milanova Vihra , The Dysregulation of microRNAs and the Role of Stress in the Pathogenesis of Mental Disorders, Current Topics in Medicinal Chemistry 2018; 18 (21) . https://dx.doi.org/10.2174/1568026619666181130135253
DOI https://dx.doi.org/10.2174/1568026619666181130135253 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?
Current Medicinal Chemistry Yin and Yang of Polyphenols in Cancer Prevention: A Short Review
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions
Current Alzheimer Research Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies
Current Neuropharmacology β-amyloid and Oxidative Stress: Perspectives in Drug Development
Current Pharmaceutical Design Recent Advances in Liver X Receptor Biology and Chemistry
Current Topics in Medicinal Chemistry NMR Structural Studies of Human Cellular Prion Proteins
Current Topics in Medicinal Chemistry Editorial (Hot Topic: Organic Solute Transporters and Diseases: Potential Therapeutic Targets)
Current Molecular Pharmacology HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research The Small GTPase Activity of the ROC Domain from LRRK2, a Parkinsons Disease Related Protein
Protein & Peptide Letters Depressed or Demented: Common CNS Drug Targets? !
Current Drug Targets - CNS & Neurological Disorders The Role of Autophagy on the Survival of Dopamine Neurons
Current Topics in Medicinal Chemistry Therapy in Prion Diseases
Current Topics in Medicinal Chemistry Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Central Nervous System Agents in Medicinal Chemistry Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer's Disease - A Translational Perspective
CNS & Neurological Disorders - Drug Targets Small Molecule TGF-beta Mimetics as Potential Neuroprotective Factors
Current Alzheimer Research The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Phytochemistry and Pharmacological Update on Tetraterpenoids
The Natural Products Journal Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Current Drug Metabolism